Ann Arbor-based biotechnology firm NanoBio Corp. has received a U.S. patent that solidifies intellectual property rights considered key to its top products, the company announced today. NanoBio, a University of Michigan spinoff firm, was awarded a patent pertaining to its platform vaccine technology and anti-infective product candidate.
Ann Arbor-based NanoBio Corp. announced today that it's signed an agreement with United Kingdom-based pharmaceutical giant GlaxoSmithKline to license its cold sore treatment still in clinical development. The deal provides $14.5 million upfront to NanoBio in addition to royalties and payments of up to $40 million if the treatment hits specific ...
The sluggish production process for the swine flu vaccine illustrates the global potential of an Ann Arbor biotech company’s technology. Antiquated vaccine production technology, which is making it difficult for manufacturers to quickly produce H1N1 flu vaccines, is creating demand for a revolutionary alternative. That's where University of Michigan spinoff ...
By Nathan Bomey and Tina Reed, AnnArbor.comA nanotechnology partnership between the University of Michigan and Ann Arbor-based NanoBio Corp. got a $9.3 million boost today, officials said. The National Institutes of Health awarded the grant to U-M to accelerate research on a mucosal vaccine based on nanoemulsion technology, which uses ...
Increasing regulatory scrutiny from the U.S. Food and Drug Administration didn’t scare Venture Investors away from funding Ann Arbor-based biotech startup NanoBio Corp. in July. But Venture Investors, which has an Ann Arbor office and some $200 million in capital under management, hopes that the FDA’s tightening regulatory standards are ...
Angela J. Cesere | AnnArbor.com AnnArbor.com's partner news site MLive.com is on a quest to find the best barbecue in ......
Get the Ann Arbor RSS Feed
AnnArbor.com